menu
    • menu
    [{"orgOrder":0,"company":"Intact Therapeutics","sponsor":"Processa Pharmaceuticals","pharmaFlowCategory":"D","therapeuticArea":"Gastroenterology","country":"U.S.A","productType":"Other Small Molecule","year":"2025","type":"Licensing Agreement","leadProduct":"PCS12852","moa":"5-HT4 receptor","graph1":"Gastroenterology","graph2":"Phase II","graph3":"Intact Therapeutics","amount2":0.46000000000000002,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Gastroenterology","amount2New":0.46000000000000002,"dosageForm":"Oral Tablet","sponsorNew":"Intact Therapeutics \/ Intact Therapeutics","highestDevelopmentStatusID":"8","companyTruncated":"Intact Therapeutics \/ Intact Therapeutics"}]

    Find Clinical Drug Pipeline Developments & Deals by Intact Therapeutics

    Menu

    Intact Therapeutics

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Intact Therapeutics

                            U.S.A arrow
                            HPAPI Summit
                            Not Confirmed

                            Intact Therapeutics

                            U.S.A arrow
                            HPAPI Summit
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : PCS12852

                            Therapeutic Area : Gastroenterology

                            Study Phase : Phase II

                            Recipient : Processa Pharmaceuticals

                            Deal Size : $455.0 million

                            Deal Type : Licensing Agreement

                            DEALS_DEV arrow-down

                            Processa Pharmaceuticals Signs Binding Term Sheet agreement with Intact Therapeutics

                            Details : The agreement grants Intact the exclusive option to license PCS12852, a best-in-class 5-HT4 receptor agonist for gastroparesis and other gastrointestinal motility disorders.

                            Product Name : PCS12852

                            Product Type : Other Small Molecule

                            Upfront Cash : Undisclosed

                            June 17, 2025

                            Lead Product(s) : PCS12852

                            Therapeutic Area : Gastroenterology

                            Highest Development Status : Phase II

                            Recipient : Processa Pharmaceuticals

                            Deal Size : $455.0 million

                            Deal Type : Licensing Agreement

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth